ProQR to Participate in Upcoming Investor Conferences

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA medicines for inherited retinal diseases (IRDs), today announced that Company management will participate in the following upcoming investor conferences:Citi’s 15th Annual BioPharma Virtual Conference
Thursday, September 10, 9:50-10:35 AM EST – Ophthalmology Panel
H.C. Wainwright 22nd Annual Global Investment Conference
Tuesday, September 15, 1:30-1:50 PM EST – Fireside Chat
Cantor Virtual Global Healthcare Conference
Wednesday, September 16, 2:00-2:30 PM EST – Fireside Chat
Chardan Virtual 4th Annual Genetic Medicines Conference
Tuesday, October 6, 4:15-4:45 PM EST – Fireside Chat
Presentation and webcast details can be found under ‘Events’ in the ‘Investors & Media’ section of the Company’s website ( Archived webcasts will be available for approximately 30 days following the presentation date.About ProQR
Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search